Participant flow

Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy. · Source last updated 2026-06-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Fulvestrant 250 mg Intramuscular Injection every 28 days

   id

   FG000

   title

   Fulvestrant 250 mg

2. description

   Fulvestrant 500 mg Intramuscular Injection every 28 days plus 500 mg on day 14

   id

   FG001

   title

   Fulvestrant 500 mg

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         30

      2. group Id

         FG001

         num Subjects

         33

      type

      Lost to Follow-up

   2. reasons

      1. group Id

         FG000

         num Subjects

         293

      2. group Id

         FG001

         num Subjects

         261

      type

      Death

   3. reasons

      1. group Id

         FG000

         num Subjects

         6

      2. group Id

         FG001

         num Subjects

         10

      type

      Withdrawal by Subject

   4. reasons

      1. group Id

         FG000

         num Subjects

         37

      2. group Id

         FG001

         num Subjects

         45

      type

      Ongoing in FU but not on treatment

   milestones

   1. achievements

      1. comment

         randomised patients

         group Id

         FG000

         num Subjects

         374

      2. comment

         randomised patients

         group Id

         FG001

         num Subjects

         362

      type

      STARTED

   2. achievements

      1. comment

         ongoing study treatment at survival follow-up data cut-off

         group Id

         FG000

         num Subjects

         8

      2. comment

         ongoing study treatment at survival follow-up data cut-off

         group Id

         FG001

         num Subjects

         13

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         366

      2. group Id

         FG001

         num Subjects

         349

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice